Weave Communications, Inc. (WEAV) Company Overview

Weave Communications, Inc., listed on the New York Stock Exchange as WEAV, provides an AI-powered patient communications, engagement, and payments platform for small and medium-sized healthcare practices in the United States and Canada. It connects the front-office tools used to answer calls, send texts, schedule appointments, collect forms, manage reviews, verify insurance, and receive payments.

A single platform built around the practice phone number

The company’s 2025 Form 10-K describes an orchestration layer combining voice, text, payments, scheduling, forms, reviews, analytics, and AI. Its telephony system uses the practice’s familiar number across calls and texts, while practice-management data can surface appointments, balances, tasks, and follow-ups during an interaction.

Weave is principally a recurring-revenue software business with hardware, payment processing, and onboarding economics. Customers pay for platform and phone services; Weave also earns a net revenue share from payment transactions, embedded lease revenue on phones, and installation fees.

Which revenue source drives the economics?

The quarter ended March 31, 2026 showed faster growth and better operating leverage, alongside cash outflow and weaker retention. Weave’s first-quarter earnings release reported record customer-location additions and said more than half of locations used embedded AI tools.

Growth came mainly from newly acquired locations

Revenue increased $9.7 million from Q1 2025. The Q1 2026 Form 10-Q attributes $8.7 million to locations acquired during the preceding 12 months and $1.0 million to existing locations. New-customer acquisition therefore remained the dominant growth driver.

Guidance implies continued mid-teens growth

The annual baseline is also improving. The company’s FY2025 results showed $239.0 million of revenue, 17.0% growth, $12.9 million of free cash flow, and a 72.1% GAAP gross margin.

Weave evolved from integrated phone software toward a broader healthcare operating layer. The milestones below changed recurring revenue, platform breadth, distribution, or governance.

1. Pre-IPO era
   The company built healthcare-communications expertise and workflow knowledge that now supports vertical AI automation.
2. 2016
   Weave began financing phone hardware through lease arrangements, formalizing the hardware-plus-software acquisition model that still affects gross margin and lease liabilities.
3. 2021
   The initial public offering brought Weave to the NYSE and supplied public-market capital for product and go-to-market expansion.
4. 2022
   Brett White became chief executive officer, bringing operating experience from Mindbody and a stronger emphasis on disciplined growth and profitability.
5. May 2025
   Weave completed the TrueLark acquisition, adding conversational AI and automation capabilities that accelerated the AI-receptionist roadmap.
6. March 2026
   A cooperation agreement with Engine Capital and 2717 Partners added two directors and introduced an active-stockholder influence on board composition and accountability.
7. May–July 2026
   Weave launched an omnichannel AI receptionist and then expanded enterprise security, automation, and insurance workflows, shifting the platform toward larger multi-location organizations.

The strategic tension: broaden the platform without losing SMB simplicity

Weave originally made enterprise-style communications usable without dedicated technology staff. AI, security, and multi-location controls can raise customer value, but also increase development, support, and compliance complexity. The challenge is serving enterprise groups without sacrificing simple deployment.

Weave’s defensibility is not a single patent. It combines authorized practice-management integrations, communications embedded in daily work, specialty workflows, payments, and data from billions of patient interactions. More context can make its automation more useful.

The omnichannel receptionist extends the installed workflow

In May 2026, Weave introduced an omnichannel AI receptionist built with Google Cloud’s Gemini Enterprise Agent Platform. It maintains context across voice and text, routes calls, hands conversations to people, and provides transcription and analytics—moving Weave toward autonomous patient-journey tasks.

What could weaken the switching-cost argument?

Most subscriptions are month-to-month, and retention is below an expansionary SaaS level. Third-party PMS vendors also control integration access. Weave offers a system-agnostic option, but losing a major integration could reduce functionality. The moat is operational rather than contractual: customers stay when workflow value exceeds switching effort.

Weave’s filing frames competition as a fragmented patchwork rather than naming a fixed peer set. Pressure comes from PMS and EHR vendors, communications providers, payment processors, CRM and marketing tools, analytics products, and specialist patient-engagement applications.

Weave sits in a high-differentiation, moderate-scale position

Weave’s position is not one isolated best-of-breed feature. It is breadth fitted to healthcare workflows. That supports cross-selling and convenience while exposing the company to several competitive fronts.

Because most contracts are month-to-month and new locations drive much of growth, the critical indicators are location additions, gross and net retention, add-on adoption, annual prepayment, and acquisition efficiency.

Why retention below 100% is the central operating question

NRR of 92% means the comparable cohort contracted after churn, expansion, and pricing, even though new locations kept total company revenue growing. Weave must therefore keep acquiring customers unless products, payments, AI, or pricing improve cohort economics. GRR of 89% shows lost revenue before expansion.

Weave remains GAAP-loss-making, but annual cash generation and non-GAAP results improved in 2025. The key question is whether gross-margin gains and discipline can outpace sales, product, and equity-compensation costs.

Operating leverage is emerging, but equity compensation remains material

At March 31, 2026, Weave had $13.2 million of finance-lease obligations and 87 active phone-hardware leases covering about $21.5 million of gross hardware. No debt lowers solvency risk, but leases and stock compensation still affect economics.

Weave has one common-stock class with one vote per share, avoiding founder-controlled dual-class voting. The 2026 proxy statement used 79,562,661 shares outstanding as of April 17, 2026.

Active-stockholder involvement changed the board in 2026

The March 2026 cooperation agreement added Ryan Dubin and Edward Robson to the board and required a search for another independent director. The group reported 3,152,525 shares. This raises pressure for execution and capital discipline.

Weave can grow through more locations, new specialties, enterprise groups, payments, and AI products. The same strategy raises execution risk because more complex workflows must remain reliable, private, and economically attractive.

Risk concentrates in execution rather than leverage

The debt-free balance sheet reduces refinancing risk. The main downside is sustained sales spending with weak retention, or AI and enterprise costs rising faster than revenue per location. Third-party dependence is structural: fewer than five vendors account for most PMS installations in some core verticals.

A valuation model should treat Weave as vertical SaaS with hardware-enabled acquisition, not pure subscription software. Consolidated gross margin includes loss-making onboarding and phones, while subscription and payments are much higher margin. The core forecast asks whether recurring revenue can outgrow acquisition and support costs.

The most useful scenario variables

A disciplined model should vary location growth, NRR, and sales intensity together. A stronger case requires AI and payments to lift revenue per location and reduce churn. A cautious case assumes new locations grow but cohort contraction keeps sales expense above 40% of revenue. Gross margin, dilution, and cash conversion should follow the same scenario logic.

What should researchers monitor next?

• NRR and GRR stabilization, with particular attention to whether NRR moves back toward 100%.
• Customer-location additions versus the sales-and-marketing share of revenue.
• Paid adoption and measurable revenue contribution from AI Receptionist and other automation products.
• Payments penetration and subscription-and-payments gross margin.
• Enterprise and Specialty Medical growth without deterioration in implementation or support economics.
• GAAP operating-loss reduction, annual free-cash-flow conversion, and stock-based compensation dilution.
• Board and capital-allocation decisions following the 2026 cooperation agreement.
• Reliability, privacy, regulatory compliance, and continued access to major PMS integrations.

Weave is a useful vertical-SaaS case study: integrated workflows can differentiate a platform, but durable value still requires retention and expansion economics to validate product breadth.